<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xml:lang="en" article-type="research-article" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Molecular Medicine Reports</journal-id>
<journal-title-group>
<journal-title>Molecular Medicine Reports</journal-title>
</journal-title-group>
<issn pub-type="ppub">1791-2997</issn>
<issn pub-type="epub">1791-3004</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/mmr.2017.6383</article-id>
<article-id pub-id-type="publisher-id">mmr-15-05-3366</article-id>
<article-categories>
<subj-group>
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Epigenetic alterations and occupational exposure to benzene, fibers, and heavy metals associated with tumor development</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Salemi</surname><given-names>Rossella</given-names></name>
<xref rid="af1-mmr-15-05-3366" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Marconi</surname><given-names>Andrea</given-names></name>
<xref rid="af2-mmr-15-05-3366" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Di Salvatore</surname><given-names>Valentina</given-names></name>
<xref rid="af1-mmr-15-05-3366" ref-type="aff">1</xref></contrib>
<contrib contrib-type="author"><name><surname>Franco</surname><given-names>Sabrina</given-names></name>
<xref rid="af3-mmr-15-05-3366" ref-type="aff">3</xref></contrib>
<contrib contrib-type="author"><name><surname>Rapisarda</surname><given-names>Venerando</given-names></name>
<xref rid="af2-mmr-15-05-3366" ref-type="aff">2</xref></contrib>
<contrib contrib-type="author"><name><surname>Libra</surname><given-names>Massimo</given-names></name>
<xref rid="af1-mmr-15-05-3366" ref-type="aff">1</xref>
<xref rid="c1-mmr-15-05-3366" ref-type="corresp"/></contrib>
</contrib-group>
<aff id="af1-mmr-15-05-3366"><label>1</label>Department of Biomedical and Biotechnological Sciences, Laboratory of Translational Oncology and Functional Genomics, Section of General and Clinical Pathology and Oncology, University of Catania, I-95123 Catania, Italy</aff>
<aff id="af2-mmr-15-05-3366"><label>2</label>Section of Occupational Medicine, Department of Clinical and Experimental Medicine, University of Catania, I-95123 Catania, Italy</aff>
<aff id="af3-mmr-15-05-3366"><label>3</label>Department of Medical, Surgical and Advanced Technology Sciences &#x2018;G.F. Ingrassia&#x2019;, University of Catania, I-95123 Catania, Italy</aff>
<author-notes>
<corresp id="c1-mmr-15-05-3366"><italic>Correspondence to</italic>: Professor Massimo Libra, Department of Biomedical and Biotechnological Sciences, Laboratory of Translational Oncology and Functional Genomics, Section of General and Clinical Pathology and Oncology, University of Catania, Torre Biologica, Via Santa Sofia 97, I-95123 Catania, Italy, E-mail: <email>m.libra@unict.it</email></corresp>
</author-notes>
<pub-date pub-type="ppub"><month>05</month><year>2017</year></pub-date>
<pub-date pub-type="epub"><day>24</day><month>03</month><year>2017</year></pub-date>
<volume>15</volume>
<issue>5</issue>
<fpage>3366</fpage>
<lpage>3371</lpage>
<history>
<date date-type="received"><day>30</day><month>12</month><year>2016</year></date>
<date date-type="accepted"><day>16</day><month>02</month><year>2017</year></date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2017, Spandidos Publications</copyright-statement>
<copyright-year>2017</copyright-year>
</permissions>
<abstract>
<p>The chronic occupational exposure to contaminants and carcinogens leads to the development of cancer. Over the past decades, many carcinogens have been found in the occupational environment and their presence is often associated with an increased incidence of cancer. According to the International Agency for Research on Cancer (IARC), the majority of carcinogens are classified as &#x2018;probable&#x2019; and &#x2018;possible&#x2019; human carcinogens, while, direct evidence of carcinogenicity is provided in epidemiological and experimental studies. Additionally, accumulating evidence suggests that epigenetic alterations may be early indicators of genotoxic and non-genotoxic carcinogen exposure. In the present review, the relationship between exposures to benzene, mineral fibers, metals and epigenetic alterations are discussed as the most important cancer risk factors during work activities.</p>
</abstract>
<kwd-group>
<kwd>benzene</kwd>
<kwd>fibers</kwd>
<kwd>heavy metals</kwd>
<kwd>occupational exposure</kwd>
<kwd>epigenetics</kwd>
<kwd>cancer</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>It is known that cancer arises from multiple factors. The identification of each factor, as the specific cause of cancer development, is the one of the main goals of cancer research. Many epidemiological studies have described the association between occupational exposures to carcinogens and cancer risk (<xref rid="b1-mmr-15-05-3366" ref-type="bibr">1</xref>). Although, the incidence of cancer has decreased in the western world, an icreased incidence rate was observed among workers exposed to carcinogens (<xref rid="b1-mmr-15-05-3366" ref-type="bibr">1</xref>&#x2013;<xref rid="b3-mmr-15-05-3366" ref-type="bibr">3</xref>). Since 2007 the International Agency for Research on Cancer (IARC) recognized 415 known or supposed cancerogens (<xref rid="b2-mmr-15-05-3366" ref-type="bibr">2</xref>). Occupational activities associated to cancer risk may be caused by different factors; therefore, it is important to better identify every single factor implicated in this machinery to apply preventive guidelines and to better understand the pathogenic mechanism of cancer development. However, in some cases, there is a significant indication of an increased risk of development of various types of cancer with specific occupational exposure (<xref rid="b4-mmr-15-05-3366" ref-type="bibr">4</xref>).</p>
<p>Several studies have shown that the risk of developing some cancers is associated with exposure to specific factors, such as non-ionizing radiation, 1,3-butadiene, benzene, natural fibers, air pollution, pesticides and solvents, polyaromatic hydrocarbons (PAHs), metal working fluids or mineral oil (<xref rid="b5-mmr-15-05-3366" ref-type="bibr">5</xref>&#x2013;<xref rid="b11-mmr-15-05-3366" ref-type="bibr">11</xref>).</p>
<p>In addition to genetic alterations, a key role in neoplastic transformation is played by epigenetic alterations (<xref rid="b12-mmr-15-05-3366" ref-type="bibr">12</xref>). For instance, it was demonstrated that chemically-induced carcinogenesis is associated with such epigenetic alterations including DNA methylation, changes of histones/chromatin structure and miRNA modifications (<xref rid="b13-mmr-15-05-3366" ref-type="bibr">13</xref>&#x2013;<xref rid="b16-mmr-15-05-3366" ref-type="bibr">16</xref>).</p>
<p>Notably, several studies have shown that established occupational risk factors preferably bind to methylated DNA regions (<xref rid="b17-mmr-15-05-3366" ref-type="bibr">17</xref>,<xref rid="b18-mmr-15-05-3366" ref-type="bibr">18</xref>). Accordingly, epigenetic changes may be considered as a predictive biomarker of carcinogen exposure able to influence the genotoxic potential of the carcinogenetic agent (<xref rid="b18-mmr-15-05-3366" ref-type="bibr">18</xref>).</p>
<p>This review summarizes the majority of the studies focusing on the relationship among epigenetic alterations, occupational risk factors and tumor development (<xref rid="tI-mmr-15-05-3366" ref-type="table">Table I</xref>). The comprension of this phenomenon will be helpful to prevent cancer development among workers.</p>
</sec>
<sec>
<label>2.</label>
<title>Benzene</title>
<p>Benzene is an aromatic hydrocarbon that is widely used in various industrial contexts such as chemical industry, refineries, plants producing tires and lubricants. It is also used in the production of pharmaceuticals, pesticides, plastics and dyes. Occupational exposure to benzene is typically cutaneous or by inhalation. The general population may also be exposed to benzene because it is in the atmosphere, particularly in the areas of high vehicular traffic and in proximity to gas stations. Cigarette smokers are also exposed to benzene as it is contained in the cigarette. It is well known that exposure to benzene increases the risk of developing cancer in various human tissues and organs (<xref rid="b2-mmr-15-05-3366" ref-type="bibr">2</xref>). In particular, it has been observed that its toxic effects may cause hematopoietic disorders such as non-Hodgkin&#x0027;s lymphoma, lymphocytic leukemia, acute myeloid leukemia (<xref rid="b19-mmr-15-05-3366" ref-type="bibr">19</xref>&#x2013;<xref rid="b23-mmr-15-05-3366" ref-type="bibr">23</xref>). Chromosomal alterations have been suggested as the most common mechanisms of malignant transformation associated to benzene exposure (<xref rid="b24-mmr-15-05-3366" ref-type="bibr">24</xref>&#x2013;<xref rid="b27-mmr-15-05-3366" ref-type="bibr">27</xref>). Most recently, epigenetic alterations, including DNA methylation, may also play a role in tumorigenesis (<xref rid="b28-mmr-15-05-3366" ref-type="bibr">28</xref>,<xref rid="b29-mmr-15-05-3366" ref-type="bibr">29</xref>). For instance, several studies have indicated that exposure to benzene induces loss of global genomic methylation (<xref rid="b28-mmr-15-05-3366" ref-type="bibr">28</xref>) and global DNA hypomethylation in human lymphoblastoid TK6 cells (<xref rid="b30-mmr-15-05-3366" ref-type="bibr">30</xref>). Similar epigenetic alterations were found in hematopoietic malignancies, particularly in patients with acute myeloid leukemia in which other genetic alterations may occur (<xref rid="b31-mmr-15-05-3366" ref-type="bibr">31</xref>,<xref rid="b32-mmr-15-05-3366" ref-type="bibr">32</xref>). On the other hand, further studies indicate that benzene induces DNA hypermethylation of the tumor suppressor genes p15 and p16 in benzene poisoning workers (<xref rid="b33-mmr-15-05-3366" ref-type="bibr">33</xref>).</p>
<p>Yu <italic>et al</italic> observed H4, H3, H3K4 histones modifications in the promoter region of the topoisomerase II&#x03B1; (Topo II&#x03B1;) in subjects exposed to benzene (<xref rid="b34-mmr-15-05-3366" ref-type="bibr">34</xref>). Therefore, the involvement of Topo II&#x03B1; in benzene-induced hematotoxicity demonstrates the relationship between histone modifications and benzene exposure. Finally, association between benzene and aberrant miRNA expression was also reported in studies of benzene-exposed workers, indicating their association with benzene-induced hemotoxicity and leukemogenesis (<xref rid="b35-mmr-15-05-3366" ref-type="bibr">35</xref>,<xref rid="b36-mmr-15-05-3366" ref-type="bibr">36</xref>).</p>
</sec>
<sec>
<label>3.</label>
<title>Natural fibers</title>
<p>Various scientific evidence has clearly demonstrated the link between the occurrence of lung cancers and malignant mesothelioma (MM) during occupational and environmental exposure to asbestos (<xref rid="b37-mmr-15-05-3366" ref-type="bibr">37</xref>,<xref rid="b38-mmr-15-05-3366" ref-type="bibr">38</xref>). However, information on molecular alterations in MM, in patients exposed to mineral fibers, are not yet fully known or much less compared to other malignancies. Although the use of asbestos has been banned in major world nations for &#x003E;20 years, the overall incidence of MM is estimated to occur in the year 2020, with a peak of incidence for this disease in the areas of occupational or environmental exposure to asbestos (<xref rid="b39-mmr-15-05-3366" ref-type="bibr">39</xref>,<xref rid="b40-mmr-15-05-3366" ref-type="bibr">40</xref>).</p>
<p>Improved understanding of molecular genetic consequences of asbestos exposure may improve cancer prevention strategies of exposed people. To date, it is known that the asbestos fibers, are affected by macrophages, generate genotoxic reactive oxygen species that in turn are able to induce DNA damage leading to genetic alterations in MM (<xref rid="b41-mmr-15-05-3366" ref-type="bibr">41</xref>&#x2013;<xref rid="b43-mmr-15-05-3366" ref-type="bibr">43</xref>). Furthermore, exposure to carcinogene fibers may cause epigenetic changes that reduce the activity of tumor suppressor genes in MM (<xref rid="b19-mmr-15-05-3366" ref-type="bibr">19</xref>,<xref rid="b44-mmr-15-05-3366" ref-type="bibr">44</xref>,<xref rid="b45-mmr-15-05-3366" ref-type="bibr">45</xref>). Accordingly, it was observed the activation of several proto-oncogenes associated with the downregulation of miRNA-127 and miRNA-34a (<xref rid="b46-mmr-15-05-3366" ref-type="bibr">46</xref>,<xref rid="b47-mmr-15-05-3366" ref-type="bibr">47</xref>). Indeed, several studies have indicated that aberrant expression of miRNAs play a role in MM development (<xref rid="b48-mmr-15-05-3366" ref-type="bibr">48</xref>&#x2013;<xref rid="b50-mmr-15-05-3366" ref-type="bibr">50</xref>).</p>
<p>Moreover, other studies have shown that epigenetic changes significantly are associated with exposure to asbestos and significantly predict clinical outcome, discriminating the malignant phenotype from normal pleura (<xref rid="b51-mmr-15-05-3366" ref-type="bibr">51</xref>).</p>
</sec>
<sec>
<label>4.</label>
<title>Heavy metals</title>
<p>The carcinogenic potential of some metals is well known since the beginning of the 19th century. The economy expansion in the major industrialized countries has been accompanied by a parallel increase in consumption of metals which are now recognized as human carcinogens. Indeed, toxic metals such as chromium, nickel and arsenic are used extensively in the steel industry, the wood pressure-treated, to form alloys, for the production of coins and batteries, as catalysts for the production of carbon nanoparticles. Therefore, in highly industrialized countries the use of these metals results in increasing incidence of human cancers (<xref rid="b2-mmr-15-05-3366" ref-type="bibr">2</xref>). Epigenetic mechanisms have been described in the pathogenesis of most common heavy metal-associated cancer types (<xref rid="b52-mmr-15-05-3366" ref-type="bibr">52</xref>,<xref rid="b53-mmr-15-05-3366" ref-type="bibr">53</xref>).</p>
<p>Chromium. Occupational exposure to chromium is primarily via inhalation; in fact, the relationship between chromium and risk of lung, nasal, and especially respiratory cancer is well-known (<xref rid="b54-mmr-15-05-3366" ref-type="bibr">54</xref>,<xref rid="b55-mmr-15-05-3366" ref-type="bibr">55</xref>). Strong mutagenic ability of chromium, due to its ability to enter the cells through the sulfate channels and to form stable chromium-DNA adducts, is also well-known (<xref rid="b56-mmr-15-05-3366" ref-type="bibr">56</xref>,<xref rid="b57-mmr-15-05-3366" ref-type="bibr">57</xref>). Epidemiological studies have shown that cancer may occur after chromium exposure even at lower limits than those permitted, according to the current regulation (<xref rid="b58-mmr-15-05-3366" ref-type="bibr">58</xref>).</p>
<p>Epigenetic mechanisms, such as hypermethylation of MLH1, have been suggested as potential mechanisms of malignant transformation during chromium exposure (<xref rid="b59-mmr-15-05-3366" ref-type="bibr">59</xref>). Accordingly, the inactivation of MLH1 causes loss of functional mismatch repair (MMR) in chromate-exposed lung cancer (<xref rid="b59-mmr-15-05-3366" ref-type="bibr">59</xref>).</p>
<p>In this regard, it was suggested that the increased dimethylation of histone H3 lysine 9 at the MLH1 promoter causes the downregulation of tumor suppressor genes, including MLH1 (<xref rid="b60-mmr-15-05-3366" ref-type="bibr">60</xref>).</p>
<sec>
<title/>
<sec>
<title>Nickel</title>
<p>Nickel and nickel compounds have been classified as human carcinogens accrding to IARC (2012) (<xref rid="b61-mmr-15-05-3366" ref-type="bibr">61</xref>). The main route of human exposure to nickel is inhalation and its toxic effects on the respiratory system are well-known (<xref rid="b61-mmr-15-05-3366" ref-type="bibr">61</xref>,<xref rid="b62-mmr-15-05-3366" ref-type="bibr">62</xref>). Exposure to various nickel compounds is associated with increased risks of lung cancer and nasal cancer (<xref rid="b63-mmr-15-05-3366" ref-type="bibr">63</xref>) although for these cancer types the most common risk factor is tobacco smoking (<xref rid="b64-mmr-15-05-3366" ref-type="bibr">64</xref>).</p>
<p>Several studies have demonstrated that the basis of nickel toxicity and carcinogenicity is in its ability to enter and accumulate into the cells (<xref rid="b65-mmr-15-05-3366" ref-type="bibr">65</xref>). These events involve epigenetic changes such as DNA methylation as well as the activation or suppression of a number of transcription factors and histone acetylation (<xref rid="b66-mmr-15-05-3366" ref-type="bibr">66</xref>,<xref rid="b67-mmr-15-05-3366" ref-type="bibr">67</xref>). In particular, <italic>in vivo</italic> and <italic>in vitro</italic> studies have shown that exposure to nickel may cause hypermethylation of the tumor suppressor gene p16 and its silencing (<xref rid="b68-mmr-15-05-3366" ref-type="bibr">68</xref>,<xref rid="b69-mmr-15-05-3366" ref-type="bibr">69</xref>). The suppressive effects of nickel on histone H4 acetylation in both yeast and mammalian cells have also been demonstrated (<xref rid="b70-mmr-15-05-3366" ref-type="bibr">70</xref>). Furthermore, previous studies have shown the loss of acetylation of H2A, H2B, H3 and H4 and the increase of H3K9 dimethylation in human lung cells exposed to soluble nickel (<xref rid="b67-mmr-15-05-3366" ref-type="bibr">67</xref>,<xref rid="b71-mmr-15-05-3366" ref-type="bibr">71</xref>).</p>
</sec>
<sec>
<title>Arsenic</title>
<p>Occupational arsenic exposure occurs mainly in the workplace through inhalation. Pesticides may contain arsenic and their effects in chronic disorders have been recently summarized (<xref rid="b72-mmr-15-05-3366" ref-type="bibr">72</xref>). Effects associated with arsenic exposure include cardiovascular and peripheral vascular disease, hematologic disorders and multiple cancers (cancers of the skin, lung, liver, urinary bladder, kidney and colon) (<xref rid="b72-mmr-15-05-3366" ref-type="bibr">72</xref>,<xref rid="b73-mmr-15-05-3366" ref-type="bibr">73</xref>).</p>
<p>The oncogenic ability of arsenic is well-known for almost 30 years (<xref rid="b74-mmr-15-05-3366" ref-type="bibr">74</xref>,<xref rid="b75-mmr-15-05-3366" ref-type="bibr">75</xref>). Over the last ten years, various scientific evidence has shown that epigenetic changes are important in arsenic carcinogenesis. Exposure to arsenic can induce DNA methylation changes such as hypomethylation and hypermethylation. These changes are typically observed in cancer. <italic>In vitro</italic> human kidney cells treated with arsenic were found both hypo- and hypermethylated (<xref rid="b76-mmr-15-05-3366" ref-type="bibr">76</xref>). Similar data were observed in TRL-1215 rat liver epithelial cell line (<xref rid="b77-mmr-15-05-3366" ref-type="bibr">77</xref>). Finally, other studies described a significant DNA hypermethylation of the promoter region of several genes including p53, p16, RASSF1A (<xref rid="b78-mmr-15-05-3366" ref-type="bibr">78</xref>,<xref rid="b79-mmr-15-05-3366" ref-type="bibr">79</xref>).</p>
</sec>
</sec>
</sec>
<sec sec-type="conclusions">
<label>5.</label>
<title>Conclusions</title>
<p>A growing body of evidence exists on occupational risk factors and cancer development. Previous studies on the association between cancer and environmental risk factors are here summarized and discussed. A better understanding of the molecular mechanisms of cancer growth in this context allow us to identify novel procedures to reduce the risk factors during work activity.</p>
<p>Several cancer research studies focused on cancer risk assessment, cancer epidemiology and mutational changes induced by carcinogens. Over the past decade, research interest has also been focused on epigenetic alterations for their specificity and inheritance from generation to generation. Accordingly, such alterations can be considered an appropriate biomarker of carcinogen exposure.</p>
<p>Based on the above, epigenetic changes, here emphasized, seem to be the most common mechanisms of carcinogenesis. In fact, the number of studies devoted to understanding the epigenetic alterations caused by exposure to chemical carcinogens is rapidly increasing.</p>
<p>Consequently, the role of this epigenetic alteration in carcinogenesis, involving DNA hypomethylation or hypermethylation, histones/chromatin structure alterations, different expression of microRNA and genetic changes, are detailed. However, other mechanisms, including the involvement of the tumor microenvironment, may be involved in malignant transformation after exposure to carcinogens, such as the asbestos-like fibers (<xref rid="b80-mmr-15-05-3366" ref-type="bibr">80</xref>). This is the case of mesothelioma in which an early marker of malignant transformation has been recently identified (<xref rid="b81-mmr-15-05-3366" ref-type="bibr">81</xref>,<xref rid="b82-mmr-15-05-3366" ref-type="bibr">82</xref>).</p>
<p>Although, great effort has been dedicated on the knowledge of epigenetic mechanisms in carcinogenesis, further studies are always encouraged especially in the context of occupational medicine.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgements</title>
<p>This study was supported in part by the Lega Italiana per la Lotta contro i Tumori (LILT).</p>
</ack>
<ref-list>
<title>References</title>
<ref id="b1-mmr-15-05-3366"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falzone</surname><given-names>L</given-names></name><name><surname>Marconi</surname><given-names>A</given-names></name><name><surname>Loreto</surname><given-names>C</given-names></name><name><surname>Franco</surname><given-names>S</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name></person-group><article-title>Occupational exposure to carcinogens: Benzene, pesticides and fibers (Review)</article-title><source>Mol Med Rep</source><volume>14</volume><fpage>4467</fpage><lpage>4474</lpage><year>2016</year><pub-id pub-id-type="pmid">27748850</pub-id><pub-id pub-id-type="pmcid">5101963</pub-id></element-citation></ref>
<ref id="b2-mmr-15-05-3366"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clapp</surname><given-names>RW</given-names></name><name><surname>Jacobs</surname><given-names>MM</given-names></name><name><surname>Loechler</surname><given-names>EL</given-names></name></person-group><article-title>Environmental and occupational causes of cancer: New evidence 2005&#x2013;2007</article-title><source>Rev Environ Health</source><volume>23</volume><fpage>1</fpage><lpage>37</lpage><year>2008</year><pub-id pub-id-type="doi">10.1515/REVEH.2008.23.1.1</pub-id><pub-id pub-id-type="pmid">18557596</pub-id><pub-id pub-id-type="pmcid">2791455</pub-id></element-citation></ref>
<ref id="b3-mmr-15-05-3366"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boffetta</surname><given-names>P</given-names></name><name><surname>Nyberg</surname><given-names>F</given-names></name></person-group><article-title>Contribution of environmental factors to cancer risk</article-title><source>Br Med Bull</source><volume>68</volume><fpage>71</fpage><lpage>94</lpage><year>2003</year><pub-id pub-id-type="doi">10.1093/bmp/ldg023</pub-id><pub-id pub-id-type="pmid">14757710</pub-id></element-citation></ref>
<ref id="b4-mmr-15-05-3366"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Blair</surname><given-names>A</given-names></name><name><surname>Marrett</surname><given-names>L</given-names></name><name><surname>Freeman</surname><given-names>Beane L</given-names></name></person-group><article-title>Occupational cancer in developed countries</article-title><source>Environ Health</source><volume>10</volume><comment>(Suppl 1)</comment><fpage>S9</fpage><year>2011</year><pub-id pub-id-type="doi">10.1186/1476-069X-10-S1-S9</pub-id><pub-id pub-id-type="pmid">21489219</pub-id><pub-id pub-id-type="pmcid">3073201</pub-id></element-citation></ref>
<ref id="b5-mmr-15-05-3366"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hardell</surname><given-names>L</given-names></name><name><surname>Carlberg</surname><given-names>M</given-names></name><name><surname>Mild</surname><given-names>KH</given-names></name></person-group><article-title>Case-control study of the association between the use of cellular and cordless telephones and malignant brain tumors diagnosed during 2000&#x2013;2003</article-title><source>Environ Res</source><volume>100</volume><fpage>232</fpage><lpage>241</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.envres.2005.04.006</pub-id><pub-id pub-id-type="pmid">16023098</pub-id></element-citation></ref>
<ref id="b6-mmr-15-05-3366"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Sathiakumar</surname><given-names>N</given-names></name><name><surname>Graff</surname><given-names>J</given-names></name><name><surname>Matthews</surname><given-names>R</given-names></name><name><surname>Delzell</surname><given-names>E</given-names></name></person-group><article-title>1,3-Butadiene and leukemia among synthetic rubber industry workers: Exposure-response relationships</article-title><source>Chem Biol Interact</source><volume>166</volume><fpage>15</fpage><lpage>24</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.cbi.2006.10.004</pub-id><pub-id pub-id-type="pmid">17123495</pub-id></element-citation></ref>
<ref id="b7-mmr-15-05-3366"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rybicki</surname><given-names>BA</given-names></name><name><surname>Neslund-Dudas</surname><given-names>C</given-names></name><name><surname>Nock</surname><given-names>NL</given-names></name><name><surname>Schultz</surname><given-names>LR</given-names></name><name><surname>Eklund</surname><given-names>L</given-names></name><name><surname>Rosbolt</surname><given-names>J</given-names></name><name><surname>Bock</surname><given-names>CH</given-names></name><name><surname>Monaghan</surname><given-names>KG</given-names></name></person-group><article-title>Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the <italic>GSTP1 Ile105Val</italic> polymorphism</article-title><source>Cancer Detect Prev</source><volume>30</volume><fpage>412</fpage><lpage>422</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.cdp.2006.09.004</pub-id><pub-id pub-id-type="pmid">17067754</pub-id><pub-id pub-id-type="pmcid">1769317</pub-id></element-citation></ref>
<ref id="b8-mmr-15-05-3366"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Agalliu</surname><given-names>I</given-names></name><name><surname>Eisen</surname><given-names>EA</given-names></name><name><surname>Kriebel</surname><given-names>D</given-names></name><name><surname>Quinn</surname><given-names>MM</given-names></name><name><surname>Wegman</surname><given-names>DH</given-names></name></person-group><article-title>A biological approach to characterizing exposure to metalworking fluids and risk of prostate cancer (United States)</article-title><source>Cancer Causes Control</source><volume>16</volume><fpage>323</fpage><lpage>331</lpage><year>2005</year><pub-id pub-id-type="doi">10.1007/s10552-004-4323-7</pub-id><pub-id pub-id-type="pmid">15953975</pub-id></element-citation></ref>
<ref id="b9-mmr-15-05-3366"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellen</surname><given-names>E</given-names></name><name><surname>Zeegers</surname><given-names>M</given-names></name><name><surname>Paulussen</surname><given-names>A</given-names></name><name><surname>Vlietinck</surname><given-names>R</given-names></name><name><surname>Vlem</surname><given-names>EV</given-names></name><name><surname>Veulemans</surname><given-names>H</given-names></name><name><surname>Buntinx</surname><given-names>F</given-names></name></person-group><article-title>Does occupational exposure to PAHs, diesel and aromatic amines interact with smoking and metabolic genetic polymorphisms to increase the risk on bladder cancer? The Belgian case control study on bladder cancer risk</article-title><source>Cancer Lett</source><volume>245</volume><fpage>51</fpage><lpage>60</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.canlet.2005.12.025</pub-id><pub-id pub-id-type="pmid">16504378</pub-id></element-citation></ref>
<ref id="b10-mmr-15-05-3366"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kellen</surname><given-names>E</given-names></name><name><surname>Zeegers</surname><given-names>MP</given-names></name><name><surname>Hond</surname><given-names>ED</given-names></name><name><surname>Buntinx</surname><given-names>F</given-names></name></person-group><article-title>Blood cadmium may be associated with bladder carcinogenesis: The Belgian case-control study on bladder cancer</article-title><source>Cancer Detect Prev</source><volume>31</volume><fpage>77</fpage><lpage>82</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.cdp.2006.12.001</pub-id><pub-id pub-id-type="pmid">17296271</pub-id></element-citation></ref>
<ref id="b11-mmr-15-05-3366"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Krishnadasan</surname><given-names>A</given-names></name><name><surname>Kennedy</surname><given-names>N</given-names></name><name><surname>Morgenstern</surname><given-names>H</given-names></name><name><surname>Ritz</surname><given-names>B</given-names></name></person-group><article-title>Estimated effects of solvents and mineral oils on cancer incidence and mortality in a cohort of aerospace workers</article-title><source>Am J Ind Med</source><volume>48</volume><fpage>249</fpage><lpage>258</lpage><year>2005</year><pub-id pub-id-type="doi">10.1002/ajim.20216</pub-id><pub-id pub-id-type="pmid">16167347</pub-id></element-citation></ref>
<ref id="b12-mmr-15-05-3366"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>S</given-names></name><name><surname>Kelly</surname><given-names>TK</given-names></name><name><surname>Jones</surname><given-names>PA</given-names></name></person-group><article-title>Epigenetics in cancer</article-title><source>Carcinogenesis</source><volume>31</volume><fpage>27</fpage><lpage>36</lpage><year>2010</year><pub-id pub-id-type="doi">10.1093/carcin/bgp220</pub-id><pub-id pub-id-type="pmid">19752007</pub-id></element-citation></ref>
<ref id="b13-mmr-15-05-3366"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herceg</surname><given-names>Z</given-names></name><name><surname>Lambert</surname><given-names>MP</given-names></name><name><surname>van Veldhoven</surname><given-names>K</given-names></name><name><surname>Demetriou</surname><given-names>C</given-names></name><name><surname>Vineis</surname><given-names>P</given-names></name><name><surname>Smith</surname><given-names>MT</given-names></name><name><surname>Straif</surname><given-names>K</given-names></name><name><surname>Wild</surname><given-names>CP</given-names></name></person-group><article-title>Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation</article-title><source>Carcinogenesis</source><volume>34</volume><fpage>1955</fpage><lpage>1967</lpage><year>2013</year><pub-id pub-id-type="doi">10.1093/carcin/bgt212</pub-id><pub-id pub-id-type="pmid">23749751</pub-id><pub-id pub-id-type="pmcid">3765050</pub-id></element-citation></ref>
<ref id="b14-mmr-15-05-3366"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>MT</given-names></name><name><surname>Guyton</surname><given-names>KZ</given-names></name><name><surname>Gibbons</surname><given-names>CF</given-names></name><name><surname>Fritz</surname><given-names>JM</given-names></name><name><surname>Portier</surname><given-names>CJ</given-names></name><name><surname>Rusyn</surname><given-names>I</given-names></name><name><surname>DeMarini</surname><given-names>DM</given-names></name><name><surname>Caldwell</surname><given-names>JC</given-names></name><name><surname>Kavlock</surname><given-names>RJ</given-names></name><name><surname>Lambert</surname><given-names>P</given-names></name><etal/></person-group><article-title>Key characteristics of carcinogens as a basis for organizing data on mechanisms of carcinogenesis</article-title><source>Environ Health Perspect</source><volume>124</volume><fpage>713</fpage><lpage>721</lpage><year>2016</year><pub-id pub-id-type="pmid">26600562</pub-id></element-citation></ref>
<ref id="b15-mmr-15-05-3366"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koturbash</surname><given-names>I</given-names></name><name><surname>Beland</surname><given-names>FA</given-names></name><name><surname>Pogribny</surname><given-names>IP</given-names></name></person-group><article-title>Role of epigenetic events in chemical carcinogenesis - A justification for incorporating epigenetic evaluations in cancer risk assessment</article-title><source>Toxicol Mech Methods</source><volume>21</volume><fpage>289</fpage><lpage>297</lpage><year>2011</year><pub-id pub-id-type="doi">10.3109/15376516.2011.557881</pub-id><pub-id pub-id-type="pmid">21495867</pub-id></element-citation></ref>
<ref id="b16-mmr-15-05-3366"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pogribny</surname><given-names>IP</given-names></name><name><surname>Rusyn</surname><given-names>I</given-names></name></person-group><article-title>Environmental toxicants, epigenetics, and cancer</article-title><source>Adv Exp Med Biol</source><volume>754</volume><fpage>215</fpage><lpage>232</lpage><year>2013</year><pub-id pub-id-type="doi">10.1007/978-1-4419-9967-2_11</pub-id><pub-id pub-id-type="pmid">22956504</pub-id><pub-id pub-id-type="pmcid">4281087</pub-id></element-citation></ref>
<ref id="b17-mmr-15-05-3366"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JX</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>West</surname><given-names>M</given-names></name><name><surname>Tang</surname><given-names>MS</given-names></name></person-group><article-title>Carcinogens preferentially bind at methylated CpG in the p53 mutational hot spots</article-title><source>Cancer Res</source><volume>58</volume><fpage>2070</fpage><lpage>2075</lpage><year>1998</year><pub-id pub-id-type="pmid">9605744</pub-id></element-citation></ref>
<ref id="b18-mmr-15-05-3366"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>BC</given-names></name><name><surname>Godleski</surname><given-names>JJ</given-names></name><name><surname>Marsit</surname><given-names>CJ</given-names></name><name><surname>Houseman</surname><given-names>EA</given-names></name><name><surname>Lopez-Fagundo</surname><given-names>CY</given-names></name><name><surname>Longacker</surname><given-names>JL</given-names></name><name><surname>Bueno</surname><given-names>R</given-names></name><name><surname>Sugarbaker</surname><given-names>DJ</given-names></name><name><surname>Nelson</surname><given-names>HH</given-names></name><name><surname>Kelsey</surname><given-names>KT</given-names></name></person-group><article-title>Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma</article-title><source>Carcinogenesis</source><volume>29</volume><fpage>1555</fpage><lpage>1559</lpage><year>2008</year><pub-id pub-id-type="doi">10.1093/carcin/bgn059</pub-id><pub-id pub-id-type="pmid">18310086</pub-id><pub-id pub-id-type="pmcid">2516493</pub-id></element-citation></ref>
<ref id="b19-mmr-15-05-3366"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lan</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Li</surname><given-names>G</given-names></name><name><surname>Vermeulen</surname><given-names>R</given-names></name><name><surname>Weinberg</surname><given-names>RS</given-names></name><name><surname>Dosemeci</surname><given-names>M</given-names></name><name><surname>Rappaport</surname><given-names>SM</given-names></name><name><surname>Shen</surname><given-names>M</given-names></name><name><surname>Alter</surname><given-names>BP</given-names></name><name><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Hematotoxicity in workers exposed to low levels of benzene</article-title><source>Science</source><volume>306</volume><fpage>1774</fpage><lpage>1776</lpage><year>2004</year><pub-id pub-id-type="doi">10.1126/science.1102443</pub-id><pub-id pub-id-type="pmid">15576619</pub-id><pub-id pub-id-type="pmcid">1256034</pub-id></element-citation></ref>
<ref id="b20-mmr-15-05-3366"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>JJ</given-names></name><name><surname>Ireland</surname><given-names>B</given-names></name><name><surname>Buckley</surname><given-names>CF</given-names></name><name><surname>Shepperly</surname><given-names>D</given-names></name></person-group><article-title>Lymphohaematopoeitic cancer mortality among workers with benzene exposure</article-title><source>Occup Environ Med</source><volume>60</volume><fpage>676</fpage><lpage>679</lpage><year>2003</year><pub-id pub-id-type="doi">10.1136/oem.60.9.676</pub-id><pub-id pub-id-type="pmid">12937190</pub-id><pub-id pub-id-type="pmcid">1740628</pub-id></element-citation></ref>
<ref id="b21-mmr-15-05-3366"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Infante</surname><given-names>PF</given-names></name><name><surname>Rinsky</surname><given-names>RA</given-names></name><name><surname>Wagoner</surname><given-names>JK</given-names></name><name><surname>Young</surname><given-names>RJ</given-names></name></person-group><article-title>Leukaemia in benzene workers</article-title><source>Lancet</source><volume>2</volume><fpage>76</fpage><lpage>78</lpage><year>1977</year><pub-id pub-id-type="doi">10.1016/S0140-6736(77)90074-5</pub-id><pub-id pub-id-type="pmid">69157</pub-id></element-citation></ref>
<ref id="b22-mmr-15-05-3366"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Infante</surname><given-names>PF</given-names></name></person-group><article-title>Benzene exposure and multiple myeloma: A detailed meta-analysis of benzene cohort studies</article-title><source>Ann N Y Acad Sci</source><volume>1076</volume><fpage>90</fpage><lpage>109</lpage><year>2006</year><pub-id pub-id-type="doi">10.1196/annals.1371.081</pub-id><pub-id pub-id-type="pmid">17119195</pub-id></element-citation></ref>
<ref id="b23-mmr-15-05-3366"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Glass</surname><given-names>DC</given-names></name><name><surname>Gray</surname><given-names>CN</given-names></name><name><surname>Jolley</surname><given-names>DJ</given-names></name><name><surname>Gibbons</surname><given-names>C</given-names></name><name><surname>Sim</surname><given-names>MR</given-names></name><name><surname>Fritschi</surname><given-names>L</given-names></name><name><surname>Adams</surname><given-names>GG</given-names></name><name><surname>Bisby</surname><given-names>JA</given-names></name><name><surname>Manuell</surname><given-names>R</given-names></name></person-group><article-title>Leukemia risk associated with low-level benzene exposure</article-title><source>Epidemiology</source><volume>14</volume><fpage>569</fpage><lpage>577</lpage><year>2003</year><pub-id pub-id-type="doi">10.1097/01.ede.0000082001.05563.e0</pub-id><pub-id pub-id-type="pmid">14501272</pub-id></element-citation></ref>
<ref id="b24-mmr-15-05-3366"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalousov&#x00E1;</surname><given-names>M</given-names></name><name><surname>Zima</surname><given-names>T</given-names></name><name><surname>Tesar</surname><given-names>V</given-names></name><name><surname>Dusilov&#x00E1;-Sulkov&#x00E1;</surname><given-names>S</given-names></name><name><surname>Skrha</surname><given-names>J</given-names></name></person-group><article-title>Advanced glycoxidation end products in chronic diseases - clinical chemistry and genetic background (Review)</article-title><source>Mutat Res</source><volume>579</volume><fpage>37</fpage><lpage>46</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.mrfmmm.2005.03.024</pub-id><pub-id pub-id-type="pmid">16084533</pub-id></element-citation></ref>
<ref id="b25-mmr-15-05-3366"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subrahmanyam</surname><given-names>VV</given-names></name><name><surname>Ross</surname><given-names>D</given-names></name><name><surname>Eastmond</surname><given-names>DA</given-names></name><name><surname>Smith</surname><given-names>MT</given-names></name></person-group><article-title>Potential role of free radicals in benzene-induced myelotoxicity and leukemia</article-title><source>Free Radic Biol Med</source><volume>11</volume><fpage>495</fpage><lpage>515</lpage><year>1991</year><pub-id pub-id-type="doi">10.1016/0891-5849(91)90063-9</pub-id><pub-id pub-id-type="pmid">1769608</pub-id></element-citation></ref>
<ref id="b26-mmr-15-05-3366"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Eastmond</surname><given-names>DA</given-names></name><name><surname>Smith</surname><given-names>MT</given-names></name></person-group><article-title>The nature of chromosomal aberrations detected in humans exposed to benzene</article-title><source>Crit Rev Toxicol</source><volume>32</volume><fpage>1</fpage><lpage>42</lpage><year>2002</year><pub-id pub-id-type="doi">10.1080/20024091064165</pub-id><pub-id pub-id-type="pmid">11846214</pub-id></element-citation></ref>
<ref id="b27-mmr-15-05-3366"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>C</given-names></name><name><surname>Ozcagli</surname><given-names>E</given-names></name><name><surname>Gangemi</surname><given-names>S</given-names></name><name><surname>Schembri</surname><given-names>F</given-names></name><name><surname>Giamb&#x00F2;</surname><given-names>F</given-names></name><name><surname>Androutsopoulos</surname><given-names>V</given-names></name><name><surname>Tsatsakis</surname><given-names>A</given-names></name><name><surname>Fenga</surname><given-names>C</given-names></name></person-group><article-title>Molecular biomarkers of oxidative stress and role of dietary factors in gasoline station attendants</article-title><source>Food Chem Toxicol</source><volume>90</volume><fpage>30</fpage><lpage>35</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.fct.2016.01.017</pub-id><pub-id pub-id-type="pmid">26827788</pub-id></element-citation></ref>
<ref id="b28-mmr-15-05-3366"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bollati</surname><given-names>V</given-names></name><name><surname>Baccarelli</surname><given-names>A</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Bonzini</surname><given-names>M</given-names></name><name><surname>Fustinoni</surname><given-names>S</given-names></name><name><surname>Cavallo</surname><given-names>D</given-names></name><name><surname>Byun</surname><given-names>HM</given-names></name><name><surname>Jiang</surname><given-names>J</given-names></name><name><surname>Marinelli</surname><given-names>B</given-names></name><name><surname>Pesatori</surname><given-names>AC</given-names></name><etal/></person-group><article-title>Changes in DNA methylation patterns in subjects exposed to low-dose benzene</article-title><source>Cancer Res</source><volume>67</volume><fpage>876</fpage><lpage>880</lpage><year>2007</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-06-2995</pub-id><pub-id pub-id-type="pmid">17283117</pub-id></element-citation></ref>
<ref id="b29-mmr-15-05-3366"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fenga</surname><given-names>C</given-names></name><name><surname>Gangemi</surname><given-names>S</given-names></name><name><surname>Costa</surname><given-names>C</given-names></name></person-group><article-title>Benzene exposure is associated with epigenetic changes (Review)</article-title><source>Mol Med Rep</source><volume>13</volume><fpage>3401</fpage><lpage>3405</lpage><year>2016</year><pub-id pub-id-type="pmid">26936331</pub-id></element-citation></ref>
<ref id="b30-mmr-15-05-3366"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabish</surname><given-names>AM</given-names></name><name><surname>Poels</surname><given-names>K</given-names></name><name><surname>Hoet</surname><given-names>P</given-names></name><name><surname>Godderis</surname><given-names>L</given-names></name></person-group><article-title>Epigenetic factors in cancer risk: Effect of chemical carcinogens on global DNA methylation pattern in human TK6 cells</article-title><source>PLoS One</source><volume>7</volume><fpage>e34674</fpage><year>2012</year><pub-id pub-id-type="doi">10.1371/journal.pone.0034674</pub-id><pub-id pub-id-type="pmid">22509344</pub-id><pub-id pub-id-type="pmcid">3324488</pub-id></element-citation></ref>
<ref id="b31-mmr-15-05-3366"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>L&#x00FC;bbert</surname><given-names>M</given-names></name><name><surname>Oster</surname><given-names>W</given-names></name><name><surname>Ludwig</surname><given-names>WD</given-names></name><name><surname>Ganser</surname><given-names>A</given-names></name><name><surname>Mertelsmann</surname><given-names>R</given-names></name><name><surname>Herrmann</surname><given-names>F</given-names></name></person-group><article-title>A switch toward demethylation is associated with the expression of myeloperoxidase in acute myeloblastic and promyelocytic leukemias</article-title><source>Blood</source><volume>80</volume><fpage>2066</fpage><lpage>2073</lpage><year>1992</year><pub-id pub-id-type="pmid">1327288</pub-id></element-citation></ref>
<ref id="b32-mmr-15-05-3366"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCubrey</surname><given-names>JA</given-names></name><name><surname>Steelman</surname><given-names>LS</given-names></name><name><surname>Franklin</surname><given-names>RA</given-names></name><name><surname>Abrams</surname><given-names>SL</given-names></name><name><surname>Chappell</surname><given-names>WH</given-names></name><name><surname>Wong</surname><given-names>EW</given-names></name><name><surname>Lehmann</surname><given-names>BD</given-names></name><name><surname>Terrian</surname><given-names>DM</given-names></name><name><surname>Basecke</surname><given-names>J</given-names></name><name><surname>Stivala</surname><given-names>F</given-names></name><etal/></person-group><article-title>Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance</article-title><source>Adv Enzyme Regul</source><volume>47</volume><fpage>64</fpage><lpage>103</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.advenzreg.2006.12.013</pub-id><pub-id pub-id-type="pmid">17382374</pub-id><pub-id pub-id-type="pmcid">2696319</pub-id></element-citation></ref>
<ref id="b33-mmr-15-05-3366"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xing</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>QF</given-names></name><name><surname>Li</surname><given-names>B</given-names></name><name><surname>Tian</surname><given-names>H</given-names></name><name><surname>Ni</surname><given-names>Y</given-names></name><name><surname>Yin</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>G</given-names></name></person-group><article-title>Methylation and expression analysis of tumor suppressor genes p15 and p16 in benzene poisoning</article-title><source>Chem Biol Interact</source><volume>184</volume><fpage>306</fpage><lpage>309</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.cbi.2009.12.028</pub-id><pub-id pub-id-type="pmid">20044985</pub-id></element-citation></ref>
<ref id="b34-mmr-15-05-3366"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>K</given-names></name><name><surname>Shi</surname><given-names>YF</given-names></name><name><surname>Yang</surname><given-names>KY</given-names></name><name><surname>Zhuang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>RH</given-names></name><name><surname>Xu</surname><given-names>X</given-names></name><name><surname>Cai</surname><given-names>G</given-names></name></person-group><article-title>Decreased topoisomerase II&#x03B1; expression and altered histone and regulatory factors of topoisomerase II&#x03B1; promoter in patients with chronic benzene poisoning</article-title><source>Toxicol Lett</source><volume>203</volume><fpage>111</fpage><lpage>117</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.toxlet.2011.02.020</pub-id><pub-id pub-id-type="pmid">21382456</pub-id></element-citation></ref>
<ref id="b35-mmr-15-05-3366"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Niu</surname><given-names>P</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>A</given-names></name></person-group><article-title>Aberrant miRNA profiles associated with chronic benzene poisoning</article-title><source>Exp Mol Pathol</source><volume>96</volume><fpage>426</fpage><lpage>430</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.yexmp.2014.04.011</pub-id><pub-id pub-id-type="pmid">24780745</pub-id></element-citation></ref>
<ref id="b36-mmr-15-05-3366"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>Niu</surname><given-names>P</given-names></name><name><surname>Tian</surname><given-names>L</given-names></name><name><surname>Gao</surname><given-names>A</given-names></name></person-group><article-title>Long non-coding RNA NR_045623 and NR_028291 involved in benzene hematotoxicity in occupationally benzene-exposed workers</article-title><source>Exp Mol Pathol</source><volume>96</volume><fpage>354</fpage><lpage>360</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.yexmp.2014.02.016</pub-id><pub-id pub-id-type="pmid">24613687</pub-id></element-citation></ref>
<ref id="b37-mmr-15-05-3366"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morinaga</surname><given-names>K</given-names></name><name><surname>Kishimoto</surname><given-names>T</given-names></name><name><surname>Sakatani</surname><given-names>M</given-names></name><name><surname>Akira</surname><given-names>M</given-names></name><name><surname>Yokoyama</surname><given-names>K</given-names></name><name><surname>Sera</surname><given-names>Y</given-names></name></person-group><article-title>Asbestos-related lung cancer and mesothelioma in Japan</article-title><source>Ind Health</source><volume>39</volume><fpage>65</fpage><lpage>74</lpage><year>2001</year><pub-id pub-id-type="doi">10.2486/indhealth.39.65</pub-id><pub-id pub-id-type="pmid">11341560</pub-id></element-citation></ref>
<ref id="b38-mmr-15-05-3366"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Norbet</surname><given-names>C</given-names></name><name><surname>Joseph</surname><given-names>A</given-names></name><name><surname>Rossi</surname><given-names>SS</given-names></name><name><surname>Bhalla</surname><given-names>S</given-names></name><name><surname>Gutierrez</surname><given-names>FR</given-names></name></person-group><article-title>Asbestos-related lung disease: A pictorial review</article-title><source>Curr Probl Diagn Radiol</source><volume>44</volume><fpage>371</fpage><lpage>382</lpage><year>2015</year><pub-id pub-id-type="doi">10.1067/j.cpradiol.2014.10.002</pub-id><pub-id pub-id-type="pmid">25444537</pub-id></element-citation></ref>
<ref id="b39-mmr-15-05-3366"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Treasure</surname><given-names>T</given-names></name></person-group><article-title>Mesothelioma: Time to take stock</article-title><source>J R Soc Med</source><volume>98</volume><fpage>455</fpage><lpage>458</lpage><year>2005</year><pub-id pub-id-type="doi">10.1258/jrsm.98.10.455</pub-id><pub-id pub-id-type="pmid">16199813</pub-id><pub-id pub-id-type="pmcid">1240101</pub-id></element-citation></ref>
<ref id="b40-mmr-15-05-3366"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kukreja</surname><given-names>J</given-names></name><name><surname>Jaklitsch</surname><given-names>MT</given-names></name><name><surname>Wiener</surname><given-names>DC</given-names></name><name><surname>Sugarbaker</surname><given-names>DJ</given-names></name><name><surname>Burgers</surname><given-names>S</given-names></name><name><surname>Baas</surname><given-names>P</given-names></name></person-group><article-title>Malignant pleural mesothelioma: Overview of the North American and European experience</article-title><source>Thorac Surg Clin</source><volume>14</volume><fpage>435</fpage><lpage>445</lpage><year>2004</year><pub-id pub-id-type="doi">10.1016/j.thorsurg.2004.06.009</pub-id><pub-id pub-id-type="pmid">15559050</pub-id></element-citation></ref>
<ref id="b41-mmr-15-05-3366"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>NS</given-names></name><name><surname>Jaurand</surname><given-names>MC</given-names></name><name><surname>Magne</surname><given-names>L</given-names></name><name><surname>Kheuang</surname><given-names>L</given-names></name><name><surname>Pinchon</surname><given-names>MC</given-names></name><name><surname>Bignon</surname><given-names>J</given-names></name></person-group><article-title>The interactions between asbestos fibers and metaphase chromosomes of rat pleural mesothelial cells in culture. A scanning and transmission electron microscopic study</article-title><source>Am J Pathol</source><volume>126</volume><fpage>343</fpage><lpage>349</lpage><year>1987</year><pub-id pub-id-type="pmid">3826298</pub-id><pub-id pub-id-type="pmcid">1899582</pub-id></element-citation></ref>
<ref id="b42-mmr-15-05-3366"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>A</given-names></name><name><surname>Wu</surname><given-names>LJ</given-names></name><name><surname>Santella</surname><given-names>RM</given-names></name><name><surname>Hei</surname><given-names>TK</given-names></name></person-group><article-title>Role of oxyradicals in mutagenicity and DNA damage induced by crocidolite asbestos in mammalian cells</article-title><source>Cancer Res</source><volume>59</volume><fpage>5922</fpage><lpage>5926</lpage><year>1999</year><pub-id pub-id-type="pmid">10606236</pub-id></element-citation></ref>
<ref id="b43-mmr-15-05-3366"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>A</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Lien</surname><given-names>YC</given-names></name><name><surname>Bao</surname><given-names>L</given-names></name><name><surname>Yu</surname><given-names>Z</given-names></name><name><surname>Hei</surname><given-names>TK</given-names></name></person-group><article-title>Genotoxic mechanisms of asbestos fibers: Role of extranuclear targets</article-title><source>Chem Res Toxicol</source><volume>20</volume><fpage>724</fpage><lpage>733</lpage><year>2007</year><pub-id pub-id-type="doi">10.1021/tx600364d</pub-id><pub-id pub-id-type="pmid">17447795</pub-id></element-citation></ref>
<ref id="b44-mmr-15-05-3366"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsou</surname><given-names>JA</given-names></name><name><surname>Galler</surname><given-names>JS</given-names></name><name><surname>Wali</surname><given-names>A</given-names></name><name><surname>Ye</surname><given-names>W</given-names></name><name><surname>Siegmund</surname><given-names>KD</given-names></name><name><surname>Groshen</surname><given-names>S</given-names></name><name><surname>Laird</surname><given-names>PW</given-names></name><name><surname>Turla</surname><given-names>S</given-names></name><name><surname>Koss</surname><given-names>MN</given-names></name><name><surname>Pass</surname><given-names>HI</given-names></name><etal/></person-group><article-title>DNA methylation profile of 28 potential marker loci in malignant mesothelioma</article-title><source>Lung Cancer</source><volume>58</volume><fpage>220</fpage><lpage>230</lpage><year>2007</year><pub-id pub-id-type="doi">10.1016/j.lungcan.2007.06.015</pub-id><pub-id pub-id-type="pmid">17659810</pub-id><pub-id pub-id-type="pmcid">2752414</pub-id></element-citation></ref>
<ref id="b45-mmr-15-05-3366"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>PA</given-names></name><name><surname>Baylin</surname><given-names>SB</given-names></name></person-group><article-title>The fundamental role of epigenetic events in cancer</article-title><source>Nat Rev Genet</source><volume>3</volume><fpage>415</fpage><lpage>428</lpage><year>2002</year><pub-id pub-id-type="pmid">12042769</pub-id></element-citation></ref>
<ref id="b46-mmr-15-05-3366"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>G</given-names></name><name><surname>Egger</surname><given-names>G</given-names></name><name><surname>Friedman</surname><given-names>JM</given-names></name><name><surname>Chuang</surname><given-names>JC</given-names></name><name><surname>Coetzee</surname><given-names>GA</given-names></name><name><surname>Jones</surname><given-names>PA</given-names></name></person-group><article-title>Specific activation of microRNA-127 with downregulation of the proto-oncogene <italic>BCL6</italic> by chromatin-modifying drugs in human cancer cells</article-title><source>Cancer Cell</source><volume>9</volume><fpage>435</fpage><lpage>443</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.ccr.2006.04.020</pub-id><pub-id pub-id-type="pmid">16766263</pub-id></element-citation></ref>
<ref id="b47-mmr-15-05-3366"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodygin</surname><given-names>D</given-names></name><name><surname>Tarasov</surname><given-names>V</given-names></name><name><surname>Epanchintsev</surname><given-names>A</given-names></name><name><surname>Berking</surname><given-names>C</given-names></name><name><surname>Knyazeva</surname><given-names>T</given-names></name><name><surname>K&#x00F6;rner</surname><given-names>H</given-names></name><name><surname>Knyazev</surname><given-names>P</given-names></name><name><surname>Diebold</surname><given-names>J</given-names></name><name><surname>Hermeking</surname><given-names>H</given-names></name></person-group><article-title>Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer</article-title><source>Cell Cycle</source><volume>7</volume><fpage>2591</fpage><lpage>2600</lpage><year>2008</year><pub-id pub-id-type="doi">10.4161/cc.7.16.6533</pub-id><pub-id pub-id-type="pmid">18719384</pub-id></element-citation></ref>
<ref id="b48-mmr-15-05-3366"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busacca</surname><given-names>S</given-names></name><name><surname>Germano</surname><given-names>S</given-names></name><name><surname>De Cecco</surname><given-names>L</given-names></name><name><surname>Rinaldi</surname><given-names>M</given-names></name><name><surname>Comoglio</surname><given-names>F</given-names></name><name><surname>Favero</surname><given-names>F</given-names></name><name><surname>Murer</surname><given-names>B</given-names></name><name><surname>Mutti</surname><given-names>L</given-names></name><name><surname>Pierotti</surname><given-names>M</given-names></name><name><surname>Gaudino</surname><given-names>G</given-names></name></person-group><article-title>MicroRNA signature of malignant mesothelioma with potential diagnostic and prognostic implications</article-title><source>Am J Respir Cell Mol Biol</source><volume>42</volume><fpage>312</fpage><lpage>319</lpage><year>2010</year><pub-id pub-id-type="doi">10.1165/rcmb.2009-0060OC</pub-id><pub-id pub-id-type="pmid">19502386</pub-id></element-citation></ref>
<ref id="b49-mmr-15-05-3366"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pass</surname><given-names>HI</given-names></name><name><surname>Goparaju</surname><given-names>C</given-names></name><name><surname>Ivanov</surname><given-names>S</given-names></name><name><surname>Donington</surname><given-names>J</given-names></name><name><surname>Carbone</surname><given-names>M</given-names></name><name><surname>Hoshen</surname><given-names>M</given-names></name><name><surname>Cohen</surname><given-names>D</given-names></name><name><surname>Chajut</surname><given-names>A</given-names></name><name><surname>Rosenwald</surname><given-names>S</given-names></name><name><surname>Dan</surname><given-names>H</given-names></name><etal/></person-group><article-title>hsa-miR-29c&#x002A; is linked to the prognosis of malignant pleural mesothelioma</article-title><source>Cancer Res</source><volume>70</volume><fpage>1916</fpage><lpage>1924</lpage><year>2010</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-09-3993</pub-id><pub-id pub-id-type="pmid">20160038</pub-id><pub-id pub-id-type="pmcid">2831149</pub-id></element-citation></ref>
<ref id="b50-mmr-15-05-3366"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kubo</surname><given-names>T</given-names></name><name><surname>Toyooka</surname><given-names>S</given-names></name><name><surname>Tsukuda</surname><given-names>K</given-names></name><name><surname>Sakaguchi</surname><given-names>M</given-names></name><name><surname>Fukazawa</surname><given-names>T</given-names></name><name><surname>Soh</surname><given-names>J</given-names></name><name><surname>Asano</surname><given-names>H</given-names></name><name><surname>Ueno</surname><given-names>T</given-names></name><name><surname>Muraoka</surname><given-names>T</given-names></name><name><surname>Yamamoto</surname><given-names>H</given-names></name><etal/></person-group><article-title>Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma</article-title><source>Clin Cancer Res</source><volume>17</volume><fpage>4965</fpage><lpage>4974</lpage><year>2011</year><pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-3040</pub-id><pub-id pub-id-type="pmid">21673066</pub-id></element-citation></ref>
<ref id="b51-mmr-15-05-3366"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Christensen</surname><given-names>BC</given-names></name><name><surname>Houseman</surname><given-names>EA</given-names></name><name><surname>Godleski</surname><given-names>JJ</given-names></name><name><surname>Marsit</surname><given-names>CJ</given-names></name><name><surname>Longacker</surname><given-names>JL</given-names></name><name><surname>Roelofs</surname><given-names>CR</given-names></name><name><surname>Karagas</surname><given-names>MR</given-names></name><name><surname>Wrensch</surname><given-names>MR</given-names></name><name><surname>Yeh</surname><given-names>RF</given-names></name><name><surname>Nelson</surname><given-names>HH</given-names></name><etal/></person-group><article-title>Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome</article-title><source>Cancer Res</source><volume>69</volume><fpage>227</fpage><lpage>234</lpage><year>2009</year><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-08-2586</pub-id><pub-id pub-id-type="pmid">19118007</pub-id><pub-id pub-id-type="pmcid">2744125</pub-id></element-citation></ref>
<ref id="b52-mmr-15-05-3366"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arita</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><article-title>Epigenetics in metal carcinogenesis: Nickel, arsenic, chromium and cadmium</article-title><source>Metallomics</source><volume>1</volume><fpage>222</fpage><lpage>228</lpage><year>2009</year><pub-id pub-id-type="doi">10.1039/b903049b</pub-id><pub-id pub-id-type="pmid">20461219</pub-id><pub-id pub-id-type="pmcid">2866119</pub-id></element-citation></ref>
<ref id="b53-mmr-15-05-3366"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salnikow</surname><given-names>K</given-names></name><name><surname>Zhitkovich</surname><given-names>A</given-names></name></person-group><article-title>Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: Nickel, arsenic, and chromium</article-title><source>Chem Res Toxicol</source><volume>21</volume><fpage>28</fpage><lpage>44</lpage><year>2008</year><pub-id pub-id-type="doi">10.1021/tx700198a</pub-id><pub-id pub-id-type="pmid">17970581</pub-id></element-citation></ref>
<ref id="b54-mmr-15-05-3366"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lang&#x00E5;rd</surname><given-names>S</given-names></name></person-group><article-title>One hundred years of chromium and cancer: A review of epidemiological evidence and selected case reports</article-title><source>Am J Ind Med</source><volume>17</volume><fpage>189</fpage><lpage>215</lpage><year>1990</year><pub-id pub-id-type="doi">10.1002/ajim.4700170205</pub-id><pub-id pub-id-type="pmid">2405656</pub-id></element-citation></ref>
<ref id="b55-mmr-15-05-3366"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gibb</surname><given-names>HJ</given-names></name><name><surname>Lees</surname><given-names>PS</given-names></name><name><surname>Pinsky</surname><given-names>PF</given-names></name><name><surname>Rooney</surname><given-names>BC</given-names></name></person-group><article-title>Lung cancer among workers in chromium chemical production</article-title><source>Am J Ind Med</source><volume>38</volume><fpage>115</fpage><lpage>126</lpage><year>2000</year><pub-id pub-id-type="doi">10.1002/1097-0274(200008)38:2&#x003C;127::AID-AJIM2&#x003E;3.3.CO;2-H</pub-id><pub-id pub-id-type="pmid">10893504</pub-id></element-citation></ref>
<ref id="b56-mmr-15-05-3366"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickens</surname><given-names>KP</given-names></name><name><surname>Patierno</surname><given-names>SR</given-names></name><name><surname>Ceryak</surname><given-names>S</given-names></name></person-group><article-title>Chromium genotoxicity: A double-edged sword</article-title><source>Chem Biol Interact</source><volume>188</volume><fpage>276</fpage><lpage>288</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.cbi.2010.04.018</pub-id><pub-id pub-id-type="pmid">20430016</pub-id><pub-id pub-id-type="pmcid">2942955</pub-id></element-citation></ref>
<ref id="b57-mmr-15-05-3366"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beyersmann</surname><given-names>D</given-names></name></person-group><article-title>Effects of carcinogenic metals on gene expression</article-title><source>Toxicol Lett</source><volume>127</volume><fpage>63</fpage><lpage>68</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S0378-4274(01)00484-2</pub-id><pub-id pub-id-type="pmid">12052642</pub-id></element-citation></ref>
<ref id="b58-mmr-15-05-3366"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>RM</given-names></name><name><surname>Bena</surname><given-names>JF</given-names></name><name><surname>Stayner</surname><given-names>LT</given-names></name><name><surname>Smith</surname><given-names>RJ</given-names></name><name><surname>Gibb</surname><given-names>HJ</given-names></name><name><surname>Lees</surname><given-names>PS</given-names></name></person-group><article-title>Hexavalent chromium and lung cancer in the chromate industry: A quantitative risk assessment</article-title><source>Risk Anal</source><volume>24</volume><fpage>1099</fpage><lpage>1108</lpage><year>2004</year><pub-id pub-id-type="doi">10.1111/j.0272-4332.2004.00512.x</pub-id><pub-id pub-id-type="pmid">15563281</pub-id></element-citation></ref>
<ref id="b59-mmr-15-05-3366"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>Y</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name><name><surname>Hirose</surname><given-names>T</given-names></name><name><surname>Nakagawa</surname><given-names>H</given-names></name><name><surname>Tsuyuguchi</surname><given-names>M</given-names></name><name><surname>Hashimoto</surname><given-names>M</given-names></name><name><surname>Sano</surname><given-names>T</given-names></name><name><surname>Ochiai</surname><given-names>A</given-names></name><name><surname>Monden</surname><given-names>Y</given-names></name></person-group><article-title>Microsatellite instability and protein expression of the DNA mismatch repair gene, <italic>hMLH1</italic>, of lung cancer in chromate-exposed workers</article-title><source>Mol Carcinog</source><volume>42</volume><fpage>150</fpage><lpage>158</lpage><year>2005</year><pub-id pub-id-type="doi">10.1002/mc.20073</pub-id><pub-id pub-id-type="pmid">15605365</pub-id></element-citation></ref>
<ref id="b60-mmr-15-05-3366"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><article-title>Modulation of histone methylation and <italic>MLH1</italic> gene silencing by hexavalent chromium</article-title><source>Toxicol Appl Pharmacol</source><volume>237</volume><fpage>258</fpage><lpage>266</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.taap.2009.04.008</pub-id><pub-id pub-id-type="pmid">19376149</pub-id><pub-id pub-id-type="pmcid">2701251</pub-id></element-citation></ref>
<ref id="b61-mmr-15-05-3366"><label>61</label><element-citation publication-type="journal"><source>International Agency for Research on Cancer: Nickel and nickel compounds, IARC monographs on the evaluation of carcinogenic risks to humans</source><volume>100C</volume><uri>http://monographs.iarc.fr/ENG/Monographs/vol100C/mono100C-10.pdf</uri><comment>Accessed</comment><month>December</month><day>12</day><year>2014</year></element-citation></ref>
<ref id="b62-mmr-15-05-3366"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Morgan</surname><given-names>LG</given-names></name><name><surname>Usher</surname><given-names>V</given-names></name></person-group><article-title>Health problems associated with nickel refining and use</article-title><source>Ann Occup Hyg</source><volume>38</volume><fpage>189</fpage><lpage>198</lpage><year>1994</year><pub-id pub-id-type="pmid">8210083</pub-id></element-citation></ref>
<ref id="b63-mmr-15-05-3366"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doll</surname><given-names>R</given-names></name><name><surname>Morgan</surname><given-names>LG</given-names></name><name><surname>Speizer</surname><given-names>FE</given-names></name></person-group><article-title>Cancers of the lung and nasal sinuses in nickel workers</article-title><source>Br J Cancer</source><volume>24</volume><fpage>623</fpage><lpage>632</lpage><year>1970</year><pub-id pub-id-type="doi">10.1038/bjc.1970.76</pub-id><pub-id pub-id-type="pmid">5503591</pub-id><pub-id pub-id-type="pmcid">2008725</pub-id></element-citation></ref>
<ref id="b64-mmr-15-05-3366"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Polesel</surname><given-names>J</given-names></name><name><surname>Franceschi</surname><given-names>S</given-names></name><name><surname>Talamini</surname><given-names>R</given-names></name><name><surname>Negri</surname><given-names>E</given-names></name><name><surname>Barzan</surname><given-names>L</given-names></name><name><surname>Montella</surname><given-names>M</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Vaccher</surname><given-names>E</given-names></name><name><surname>Franchin</surname><given-names>G</given-names></name><name><surname>La Vecchia</surname><given-names>C</given-names></name><etal/></person-group><article-title>Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population</article-title><source>Oral Oncol</source><volume>47</volume><fpage>541</fpage><lpage>545</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.oraloncology.2011.03.017</pub-id><pub-id pub-id-type="pmid">21478046</pub-id></element-citation></ref>
<ref id="b65-mmr-15-05-3366"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denkhaus</surname><given-names>E</given-names></name><name><surname>Salnikow</surname><given-names>K</given-names></name></person-group><article-title>Nickel essentiality, toxicity, and carcinogenicity</article-title><source>Crit Rev Oncol Hematol</source><volume>42</volume><fpage>35</fpage><lpage>56</lpage><year>2002</year><pub-id pub-id-type="doi">10.1016/S1040-8428(01)00214-1</pub-id><pub-id pub-id-type="pmid">11923067</pub-id></element-citation></ref>
<ref id="b66-mmr-15-05-3366"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karaczyn</surname><given-names>AA</given-names></name><name><surname>Golebiowski</surname><given-names>F</given-names></name><name><surname>Kasprzak</surname><given-names>KS</given-names></name></person-group><article-title>Truncation, deamidation, and oxidation of histone H2B in cells cultured with nickel (II)</article-title><source>Chem Res Toxicol</source><volume>18</volume><fpage>1934</fpage><lpage>1942</lpage><year>2005</year><pub-id pub-id-type="doi">10.1021/tx050122a</pub-id><pub-id pub-id-type="pmid">16359184</pub-id></element-citation></ref>
<ref id="b67-mmr-15-05-3366"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golebiowski</surname><given-names>F</given-names></name><name><surname>Kasprzak</surname><given-names>KS</given-names></name></person-group><article-title>Inhibition of core histones acetylation by carcinogenic nickel (II)</article-title><source>Mol Cell Biochem</source><volume>279</volume><fpage>133</fpage><lpage>139</lpage><year>2005</year><pub-id pub-id-type="doi">10.1007/s11010-005-8285-1</pub-id><pub-id pub-id-type="pmid">16283522</pub-id></element-citation></ref>
<ref id="b68-mmr-15-05-3366"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kowara</surname><given-names>R</given-names></name><name><surname>Salnikow</surname><given-names>K</given-names></name><name><surname>Diwan</surname><given-names>BA</given-names></name><name><surname>Bare</surname><given-names>RM</given-names></name><name><surname>Waalkes</surname><given-names>MP</given-names></name><name><surname>Kasprzak</surname><given-names>KS</given-names></name></person-group><article-title>Reduced Fhit protein expression in nickel-transformed mouse cells and in nickel-induced murine sarcomas</article-title><source>Mol Cell Biochem</source><volume>255</volume><fpage>195</fpage><lpage>202</lpage><year>2004</year><pub-id pub-id-type="doi">10.1023/B:MCBI.0000007275.22785.91</pub-id><pub-id pub-id-type="pmid">14971660</pub-id></element-citation></ref>
<ref id="b69-mmr-15-05-3366"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Govindarajan</surname><given-names>B</given-names></name><name><surname>Klafter</surname><given-names>R</given-names></name><name><surname>Miller</surname><given-names>MS</given-names></name><name><surname>Mansur</surname><given-names>C</given-names></name><name><surname>Mizesko</surname><given-names>M</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name><name><surname>LaMontagne</surname><given-names>K</given-names><suffix>Jr</suffix></name><name><surname>Arbiser</surname><given-names>JL</given-names></name></person-group><article-title>Reactive oxygen-induced carcinogenesis causes hypermethylation of p16(Ink4a) and activation of MAP kinase</article-title><source>Mol Med</source><volume>8</volume><fpage>1</fpage><lpage>8</lpage><year>2002</year><pub-id pub-id-type="pmid">11984000</pub-id><pub-id pub-id-type="pmcid">2039931</pub-id></element-citation></ref>
<ref id="b70-mmr-15-05-3366"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broday</surname><given-names>L</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Kuo</surname><given-names>MH</given-names></name><name><surname>Salnikow</surname><given-names>K</given-names></name><name><surname>Zoroddu</surname><given-names>M</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><article-title>Nickel compounds are novel inhibitors of histone H4 acetylation</article-title><source>Cancer Res</source><volume>60</volume><fpage>238</fpage><lpage>241</lpage><year>2000</year><pub-id pub-id-type="pmid">10667566</pub-id></element-citation></ref>
<ref id="b71-mmr-15-05-3366"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ke</surname><given-names>Q</given-names></name><name><surname>Kluz</surname><given-names>T</given-names></name><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Costa</surname><given-names>M</given-names></name></person-group><article-title>Nickel ions increase histone H3 lysine 9 dimethylation and induce transgene silencing</article-title><source>Mol Cell Biol</source><volume>26</volume><fpage>3728</fpage><lpage>3737</lpage><year>2006</year><pub-id pub-id-type="doi">10.1128/MCB.26.10.3728-3737.2006</pub-id><pub-id pub-id-type="pmid">16648469</pub-id><pub-id pub-id-type="pmcid">1488989</pub-id></element-citation></ref>
<ref id="b72-mmr-15-05-3366"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gangemi</surname><given-names>S</given-names></name><name><surname>Miozzi</surname><given-names>E</given-names></name><name><surname>Teodoro</surname><given-names>M</given-names></name><name><surname>Briguglio</surname><given-names>G</given-names></name><name><surname>De Luca</surname><given-names>A</given-names></name><name><surname>Alibrando</surname><given-names>C</given-names></name><name><surname>Polito</surname><given-names>I</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name></person-group><article-title>Occupational exposure to pesticides as a possible risk factor for the development of chronic diseases in humans (Review)</article-title><source>Mol Med Rep</source><volume>14</volume><fpage>4475</fpage><lpage>4488</lpage><year>2016</year><pub-id pub-id-type="pmid">27748877</pub-id><pub-id pub-id-type="pmcid">5101964</pub-id></element-citation></ref>
<ref id="b73-mmr-15-05-3366"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tchounwou</surname><given-names>PB</given-names></name><name><surname>Centeno</surname><given-names>JA</given-names></name><name><surname>Patlolla</surname><given-names>AK</given-names></name></person-group><article-title>Arsenic toxicity, mutagenesis, and carcinogenesis - A health risk assessment and management approach</article-title><source>Mol Cell Biochem</source><volume>255</volume><fpage>47</fpage><lpage>55</lpage><year>2004</year><pub-id pub-id-type="doi">10.1023/B:MCBI.0000007260.32981.b9</pub-id><pub-id pub-id-type="pmid">14971645</pub-id></element-citation></ref>
<ref id="b74-mmr-15-05-3366"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barrett</surname><given-names>JC</given-names></name><name><surname>Lamb</surname><given-names>PW</given-names></name><name><surname>Wang</surname><given-names>TC</given-names></name><name><surname>Lee</surname><given-names>TC</given-names></name></person-group><article-title>Mechanisms of arsenic-induced cell transformation</article-title><source>Biol Trace Elem Res</source><volume>21</volume><fpage>421</fpage><lpage>429</lpage><year>1989</year><pub-id pub-id-type="doi">10.1007/BF02917284</pub-id><pub-id pub-id-type="pmid">2484623</pub-id></element-citation></ref>
<ref id="b75-mmr-15-05-3366"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TC</given-names></name><name><surname>Tanaka</surname><given-names>N</given-names></name><name><surname>Lamb</surname><given-names>PW</given-names></name><name><surname>Gilmer</surname><given-names>TM</given-names></name><name><surname>Barrett</surname><given-names>JC</given-names></name></person-group><article-title>Induction of gene amplification by arsenic</article-title><source>Science</source><volume>241</volume><fpage>79</fpage><lpage>81</lpage><year>1988</year><pub-id pub-id-type="doi">10.1126/science.3388020</pub-id><pub-id pub-id-type="pmid">3388020</pub-id></element-citation></ref>
<ref id="b76-mmr-15-05-3366"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baylin</surname><given-names>SB</given-names></name><name><surname>Herman</surname><given-names>JG</given-names></name></person-group><article-title>DNA hypermethylation in tumorigenesis: Epigenetics joins genetics</article-title><source>Trends Genet</source><volume>16</volume><fpage>168</fpage><lpage>174</lpage><year>2000</year><pub-id pub-id-type="doi">10.1016/S0168-9525(99)01971-X</pub-id><pub-id pub-id-type="pmid">10729832</pub-id></element-citation></ref>
<ref id="b77-mmr-15-05-3366"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>CQ</given-names></name><name><surname>Young</surname><given-names>MR</given-names></name><name><surname>Diwan</surname><given-names>BA</given-names></name><name><surname>Coogan</surname><given-names>TP</given-names></name><name><surname>Waalkes</surname><given-names>MP</given-names></name></person-group><article-title>Association of arsenic-induced malignant transformation with DNA hypomethylation and aberrant gene expression</article-title><source>Proc Natl Acad Sci USA</source><volume>94</volume><fpage>10907</fpage><lpage>10912</lpage><year>1997</year><pub-id pub-id-type="doi">10.1073/pnas.94.20.10907</pub-id><pub-id pub-id-type="pmid">9380733</pub-id><pub-id pub-id-type="pmcid">23527</pub-id></element-citation></ref>
<ref id="b78-mmr-15-05-3366"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chanda</surname><given-names>S</given-names></name><name><surname>Dasgupta</surname><given-names>UB</given-names></name><name><surname>Guhamazumder</surname><given-names>D</given-names></name><name><surname>Gupta</surname><given-names>M</given-names></name><name><surname>Chaudhuri</surname><given-names>U</given-names></name><name><surname>Lahiri</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>S</given-names></name><name><surname>Ghosh</surname><given-names>N</given-names></name><name><surname>Chatterjee</surname><given-names>D</given-names></name></person-group><article-title>DNA hypermethylation of promoter of gene p53 and p16 in arsenic-exposed people with and without malignancy</article-title><source>Toxicol Sci</source><volume>89</volume><fpage>431</fpage><lpage>437</lpage><year>2006</year><pub-id pub-id-type="doi">10.1093/toxsci/kfj030</pub-id><pub-id pub-id-type="pmid">16251483</pub-id></element-citation></ref>
<ref id="b79-mmr-15-05-3366"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>X</given-names></name><name><surname>Wakai</surname><given-names>T</given-names></name><name><surname>Shirai</surname><given-names>Y</given-names></name><name><surname>Hatakeyama</surname><given-names>K</given-names></name><name><surname>Hirano</surname><given-names>S</given-names></name></person-group><article-title>Chronic oral exposure to inorganic arsenate interferes with methylation status of p16<sup>INK4a</sup> and RASSF1A and induces lung cancer in A/J mice</article-title><source>Toxicol Sci</source><volume>91</volume><fpage>372</fpage><lpage>381</lpage><year>2006</year><pub-id pub-id-type="doi">10.1093/toxsci/kfj159</pub-id><pub-id pub-id-type="pmid">16543296</pub-id></element-citation></ref>
<ref id="b80-mmr-15-05-3366"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miozzi</surname><given-names>E</given-names></name><name><surname>Rapisarda</surname><given-names>V</given-names></name><name><surname>Marconi</surname><given-names>A</given-names></name><name><surname>Costa</surname><given-names>C</given-names></name><name><surname>Polito</surname><given-names>I</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name><name><surname>Fenga</surname><given-names>C</given-names></name></person-group><article-title>Fluoro-edenite and carbon nanotubes: The health impact of &#x2018;asbestos-like&#x2019; fibres</article-title><source>Exp Ther Med</source><volume>11</volume><fpage>21</fpage><lpage>27</lpage><year>2016</year><pub-id pub-id-type="pmid">26889212</pub-id></element-citation></ref>
<ref id="b81-mmr-15-05-3366"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapisarda</surname><given-names>V</given-names></name><name><surname>Salemi</surname><given-names>R</given-names></name><name><surname>Marconi</surname><given-names>A</given-names></name><name><surname>Loreto</surname><given-names>C</given-names></name><name><surname>Graziano</surname><given-names>AC</given-names></name><name><surname>Cardile</surname><given-names>V</given-names></name><name><surname>Basile</surname><given-names>MS</given-names></name><name><surname>Candido</surname><given-names>S</given-names></name><name><surname>Falzone</surname><given-names>L</given-names></name><name><surname>Spandidos</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Fluoro-edenite induces fibulin-3 overexpression in non-malignant human mesothelial cells</article-title><source>Oncol Lett</source><volume>12</volume><fpage>3363</fpage><lpage>3367</lpage><year>2016</year><pub-id pub-id-type="pmid">27900005</pub-id><pub-id pub-id-type="pmcid">5103952</pub-id></element-citation></ref>
<ref id="b82-mmr-15-05-3366"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rapisarda</surname><given-names>V</given-names></name><name><surname>Ledda</surname><given-names>C</given-names></name><name><surname>Migliore</surname><given-names>M</given-names></name><name><surname>Salemi</surname><given-names>R</given-names></name><name><surname>Musumeci</surname><given-names>A</given-names></name><name><surname>Bracci</surname><given-names>M</given-names></name><name><surname>Marconi</surname><given-names>A</given-names></name><name><surname>Loreto</surname><given-names>C</given-names></name><name><surname>Libra</surname><given-names>M</given-names></name></person-group><article-title>FBLN-3 as a biomarker of pleural plaques in workers occupationally exposed to carcinogenic fibers: A pilot study</article-title><source>Future Oncol</source><volume>11</volume><comment>(Suppl)</comment><fpage>35</fpage><lpage>37</lpage><year>2015</year><pub-id pub-id-type="doi">10.2217/fon.15.271</pub-id><pub-id pub-id-type="pmid">26638921</pub-id></element-citation></ref>
</ref-list>
</back>
<floats-group>
<table-wrap id="tI-mmr-15-05-3366" position="float">
<label>Table I.</label>
<caption><p>Occupational exposure to carcinogenic agents and epigenetic alterations.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" valign="bottom">Carcinogenic agent</th>
<th align="center" valign="bottom">Uses and source</th>
<th align="center" valign="bottom">Cancer type</th>
<th align="center" valign="bottom">Epigenetic alterations</th>
<th align="center" valign="bottom">Author/(refs)</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" valign="top">Benzene</td>
<td align="left" valign="top">Chemical industry, refineries, gas stations, pharmaceuticals, pesticides, plastic and dyes and cigarette</td>
<td align="left" valign="top">NHL, AML</td>
<td align="left" valign="top">Chromosomal alteration, DNA hypomethylation and hypermethylation, histones modifications, aberrant miRNA expression</td>
<td align="left" valign="top">Kalousov&#x00E1; <italic>et al</italic> (<xref rid="b24-mmr-15-05-3366" ref-type="bibr">24</xref>), Subrahmanyam <italic>et al</italic> (<xref rid="b25-mmr-15-05-3366" ref-type="bibr">25</xref>), Zhang <italic>et al</italic> (<xref rid="b26-mmr-15-05-3366" ref-type="bibr">26</xref>), Costa <italic>et al</italic> (<xref rid="b27-mmr-15-05-3366" ref-type="bibr">27</xref>), Bollati <italic>et al</italic> (<xref rid="b28-mmr-15-05-3366" ref-type="bibr">28</xref>), Fenga <italic>et al</italic> (<xref rid="b29-mmr-15-05-3366" ref-type="bibr">29</xref>), Tabish <italic>et al</italic> (<xref rid="b30-mmr-15-05-3366" ref-type="bibr">30</xref>), Yu <italic>et al</italic> (<xref rid="b34-mmr-15-05-3366" ref-type="bibr">34</xref>), Bai <italic>et al</italic> (<xref rid="b35-mmr-15-05-3366" ref-type="bibr">35</xref>), Bai <italic>et al</italic> (<xref rid="b36-mmr-15-05-3366" ref-type="bibr">36</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Asbestos (fibrous silicate particles)</td>
<td align="left" valign="top">Acoustical thermal insulation, railway construction and building construction</td>
<td align="left" valign="top">Mesothelioma</td>
<td align="left" valign="top">Promoter methylation, miRNAs downregulation</td>
<td align="left" valign="top">Tsou <italic>et al</italic> (<xref rid="b44-mmr-15-05-3366" ref-type="bibr">44</xref>), Jones and Baylin (<xref rid="b45-mmr-15-05-3366" ref-type="bibr">45</xref>), Christensen <italic>et al</italic> (<xref rid="b18-mmr-15-05-3366" ref-type="bibr">18</xref>), Saito <italic>et al</italic> (<xref rid="b46-mmr-15-05-3366" ref-type="bibr">46</xref>), Lodygin <italic>et al</italic> (<xref rid="b47-mmr-15-05-3366" ref-type="bibr">47</xref>), Busacca <italic>et al</italic> (<xref rid="b48-mmr-15-05-3366" ref-type="bibr">48</xref>), Pass <italic>et al</italic> (<xref rid="b49-mmr-15-05-3366" ref-type="bibr">49</xref>), Kubo <italic>et al</italic> (<xref rid="b50-mmr-15-05-3366" ref-type="bibr">50</xref>), Christensen <italic>et al</italic> (<xref rid="b51-mmr-15-05-3366" ref-type="bibr">51</xref>),</td>
</tr>
<tr>
<td align="left" valign="top">Chromium production, chrome</td>
<td align="left" valign="top">Steel and end alloy planting, dyes and pigments manufacture</td>
<td align="left" valign="top">Lung cancer</td>
<td align="left" valign="top">DNA hypomethylation</td>
<td align="left" valign="top">Takahashi <italic>et al</italic> (<xref rid="b59-mmr-15-05-3366" ref-type="bibr">59</xref>), Sun <italic>et al</italic> (<xref rid="b60-mmr-15-05-3366" ref-type="bibr">60</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Nickel</td>
<td align="left" valign="top">Nickel planting and battery production</td>
<td align="left" valign="top">Lung cancer, nasopharyngeal</td>
<td align="left" valign="top">DNA hypomethylation and hypermethylation, Histone acetylation</td>
<td align="left" valign="top">Karaczyn <italic>et al</italic> (<xref rid="b66-mmr-15-05-3366" ref-type="bibr">66</xref>), Golebiowski and Kasprzak (<xref rid="b67-mmr-15-05-3366" ref-type="bibr">67</xref>), Kowara <italic>et al</italic> (<xref rid="b68-mmr-15-05-3366" ref-type="bibr">68</xref>), Govindarajan <italic>et al</italic> (<xref rid="b69-mmr-15-05-3366" ref-type="bibr">69</xref>), Broday <italic>et al</italic> (<xref rid="b70-mmr-15-05-3366" ref-type="bibr">70</xref>), Chen <italic>et al</italic> (<xref rid="b71-mmr-15-05-3366" ref-type="bibr">71</xref>)</td>
</tr>
<tr>
<td align="left" valign="top">Arsenic</td>
<td align="left" valign="top">Pesticides</td>
<td align="left" valign="top">Cancer of skin, liver, urinary tract, lung, colon and hematopoietic disorders</td>
<td align="left" valign="top">DNA hypomethylation and hypermethylation</td>
<td align="left" valign="top">Baylin and Herman (<xref rid="b76-mmr-15-05-3366" ref-type="bibr">76</xref>), Zhao <italic>et al</italic> (<xref rid="b77-mmr-15-05-3366" ref-type="bibr">77</xref>), Chanda <italic>et al</italic> (<xref rid="b78-mmr-15-05-3366" ref-type="bibr">78</xref>), Cui <italic>et al</italic> (<xref rid="b79-mmr-15-05-3366" ref-type="bibr">79</xref>)</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
